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Summary A study was conducted on the effects of 12-0-tetradecanoyl-phorbol-13-acetate (TPA) on
peroxisomal enzyme activities in mouse embryo fibroblasts C3H/lOTl/2 C18 cells and chemically transformed
C3H/lOTl/2 MCA16 cells. TPA is a potent tumour promoter and treatment with this compound of the two
cell lines induced peroxisomal fatty acid ,B-oxidation, carnitine acetyltransferase, palmitoyl-CoA hydrolase,
and catalase activities after 240h of treatment. Stimulation of the corresponding enzyme activities was dose-
related and cycloheximide inhibited the TPA-induced enzyme activities, except that of carnitine
acetyltransferase. The MCA16 cells appeared to be more sensitive than the C18 cells in inducing peroxisome-
associated enzyme activities after TPA treatment. The activities of the microsomal marker, NADPH-
cytochrome c reductase and the mitochondrial marker, glutamate dehydrogenase were not enhanced by TPA
treatment. The results indicate that TPA has peroxisomal effects and may be classified as a peroxisome
proliferator.
Long-chain dialkyl phthalates (Kluwe et al., 1982,
1983) and some hypolipidemic drugs (Reddy &
Rao, 1977; Reddy & Qureshi, 1979; Fitzgerald et
al., 1981) have produced liver cancer in rats and
mice following administration for a prolonged
period at high dose levels. These agents have also
been described as peroxisome proliferators in
rodent liver (Reddy et al., 1974; Leighton et al.,
1975) and it has been suggested that peroxisome
proliferators as a class are carcinogenic (Reddy et
al., 1980). Peroxisome proliferating agents are also
associated with an increase in the activities of some
enzymes, i.e. cyanide-insensitive palmityol-CoA
dehydrogenase (usually termed peroxisomal ,B-
oxidation), catalase, carnitine acetyltransferase and
cytosolic palmitoyl-CoA hydrolase (Reddy et al.,
1974; Moody & Reddy, 1978; Inestrosa et al., 1979;
Berge et al., 1981; Berge & Bakke, 1981; Berge et
al., 1983). Hypolipidemic drugs as well as phthalates
have been found not to be genotoxic (Warren et al.,
1980; Von Daniken et al., 1984). Thus, these
compounds may be termed epigenetic carcinogens.
The negative results in genotoxicity assays
suggested that peroxisome proliferators may have
exerted their weak carcinogenic response through a
promotional mechanism. Therefore, it would be of
interest to establish whether a classical tumour
promoter exerts a peroxisomal effect.
12-O-tetradecanoylphorbol-13-acetate (TPA) is a
potent tumour promoter and it is the most active
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phorbol ester examined. The molecular mechanism
of action of tumour promoters are not fully
understood. TPA appears to be a membrane active
agent, presumably through its interaction with high-
affinity, saturable receptors. These receptors appear
to be the calcium and lipid binding protein kinase
C that is activated by TPA (Hicks, 1983; Blumberg,
1981). TPA also alters the metabolism of the
intracellular membrane components. A specific
enhancement of choline incorporation into the
nuclear associated reticulum of the C3H/1OT1/2
C18 cells has been reported (Pryme et al., 1983).
Backer et al. (1982) have shown that TPA inhibits
mitochondrial respiration in C3H/IOTI/2 mouse
fibroblasts at nanomolar concentrations. Moreover,
TPA has been shown to increase generation of 02
and H202 and chemiluminescence (Goldstein et al.,
1975; Kensler & Trush, 1981). However, there is
considerable speculation on the role of 02 in
carcinogenesis. Thus it is still unproven whether
reactive oxygen species appear to have a role in the
multiple steps in chemical carcinogenesis and their
involvement in the mechanism of tumour
promotion by TPA.
Increased H202 generation has been observed in
the livers of rats administered peroxisome
proliferators (Lalwani et al., 1981). Prolonged
exposure to peroxisome proliferators results in the
excessive accumulation of autofluorescent lipofusion
in the liver (Reddy et al., 1982), providing indirect
evidence for the increased production of biologically
damaging free radicals.
Recently, we have shown that the two different
hypolipidemic drugs clolibrate and niadenate are
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tumour promoters when assayed in mouse embryo
fibroblasts C3H/IOT1/2 C18 cells (Lillehaug et al.,
1985). The purpose of this study was therefore to
investigate the response of these cells to a known
peroxisome proliferator and to TPA. Peroxisomal
changes were assessed by measuring the bio-
chemical markers for peroxisomal fl-oxidation,
carnitine acetyltransferase, catalase and palmitoyl-
CoA hydrolase. The present study shows that TPA
treatment selectively enhanced the activities of these
peroxisome-associated enzymes, but not NADPH-
cytochrome c reductase and glutamate dehydro-
genase, thus providing indirect evidence that TPA,
a tumour promoter, can also be a peroxisome-
proliferating agent.
Materials and methods
Cell cultures
The mouse embryo fibroblasts, C3H/lOTI/2 C18
and the chemically transformed C3H/lOT/2 MCA16
cells were grown in Basal Medium Eagle
supplemented with 10% heat-inactivated foetal calf
serum and incubated at 37°C in a humidified
atmosphere of 5% CO2 in air. TPA and tiadenol
was dissolved in acetone and stored in ambre
bottles at -20°C. The acetone concentration in the
medium was always kept below 0.5%. The C18 cells
were seeded at 2 x I04 cells per dish (100 mm,
Costar) so that the cultures reached confluence on
day 9. The MCA16 cells were seeded at 5 x 103 cells
per dish (60mm, Nunc). The drug treatment was
always repeated 24 h before the cells were harvested.
Other details of growth conditions are given in
figure legends.
Preparation ofpostnuclearfraction
The cells were harvested at the time desired, washed
with cold PBS, scraped off the dish in 1ml of
10mM HEPES buffer, pH 7.4 and 0.25 mM sucrose.
The cells were homogenized in a Bellco glass
homogenizer using piston A (4 strokes). The
supernatant after centrifugation at 800 r.p.m. for
5 min in the Sorval GLC 2B centrifuge was defined
as the postnuclear fraction. This subcellular
preparation was routinely used in this study.
However, both the sedimentation pellet and the
whole cell homogenate were also analyzed for
enzyme activities.
Enzyme assays
Palmitoyl-CoA hydrolase activity was assayed both
radioactively and spectrophotometrically as des-
cribed previously (Berge & Farstad, 1979; Berge &
D0ssland, 1979). The incubation medium contained
15 mM HEPES buffer, pH 7.4, 150mM KCl, 2 mM
EDTA, 0.01% (W/W) Triton X-100 and palmitoyl-
CoA. When the spectrophotometric method was used,
0.3 mM DTNB was added in order to trap free
CoASH. The protein content per assay was kept in
the range from 5 to 50pg. For further experimental
details, see Results. The activities of cyanide-
insensitive palmitoyl-CoA oxidase, catalase, urate
oxidase and carnitine acetyltransferase were assayed
according to earlier procedures (Berge & Bakke,
1981). Protein was determined using the Bio-Rad
protein assay kit (Bio-Rad Lab., USA). Standard
protein was bovine gamma globulin.
Reagents
Basal Medium Eagle and heat-inactivated foetal calf
serum were from Gibco, Scotland. Plastic petri
dishes were either from Nunc, Denmark or from
Costar, Mass., USA. Palmitoyl-CoA and cyclo-
heximide were from Sigma Chemical Co. (St Louis,
MO, USA).
[1-`4C] palmitoyl-CoA was purchased from New
England Nuclear, Boston, MA, USA. TPA was
obtained from PL/Biochemicals, USA. Tiadenol was
a gift from Laboratorios Almirall, Barcelona, Spain.
All other chemicals were of highest purity
commercially available.
Results
With a prepared postnuclear fraction of mouse
embryo fibroblast C3H/IOT1/2 C18 cells, the
hydrolysis of palmitoyl-CoA was linear with the
amount of protein up to -50pg (Figure 1). The
rate of hydrolysis of palmitoyl-CoA by the
corresponding cell fraction was constant up to
- 6 min (data not shown). When the C18 cells were
cultured in the presence of a non-toxic
concentration of TPA (20 nM) for 9 days, the
specific activity of the palmitoyl-CoA hydrolase
activity (24.6 nmolmin-' mg-' protein) was
increased -2.5 fold compared to control cells
(9.7 nmol min- mg-1 protein) (Figure 1). Tiadenol
administration, a potent hypolipidemic drug (Berge
& Bakke, 1981) also enhanced this enzyme activity
in the C18 cells and MCA16 cells (Berge &
Lillehaug, 1985). When the C18 cells were cultured
in the presence of 2OnM TPA for 24h, the activity
of the palmitoyl-CoA hydrolase activity declined
-30% (Figure 2). However, after this period there
was a progressive increase in palmitoyl-CoA
hydrolase activity up to 240h. The palmitoyl-CoA
hydrolase specific activity of untreated cells was
constant during this growth period. For longer time
of cell growth the hydrolase activity decreasedPEROXISOME PROLIFERATION OF TPA IN VITRO 123
0 20 40 60
Protein (,ug)
Figure 1 Hydrolysis of palmitoyl-CoA in the post-
nuclear fraction from C3H/IOTI/2 C18 cells as a
function of protein. The concentration of palmitoyl-
CoA was 150,M in a total volume of 0.25 ml.
C3H/lOTI/2 C18 cells were cultured for 9 days with
20nM TPA (0); the control cultures received 0.5%
acetone (0). The cells were treated during the
logarithmic growth phase and the cultures reached
confluence on day 9.
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Figure 2 Changes in the level of palmitoyl-CoA
hydrolase (0) and catalase (0) in C18 cells treated
with 20nM TPA. The results are expressed as percent
of control. The values are mean+s.d. (n =3); O
represents the value of palmityol-CoA hydrolase
activity obtained from TPA treated MCA16 cells. TPA
treatment was started on the 4th day of culture. The
cells were then in early log-phase growth (Berge &
Lillehaug, 1985). The control values at time zero for
palmitoyl-CoA hydrolase and catalase activities were
12 nmolmin- I mg-1 protein and 10 nmolmin 1mg '
protein, respectively.
0
possibly due to a larger portion of the cells entering
the G1/Go-phase (Berge & Lillehaug, 1985). The
palmitoyl-CoA hydrolase activity was also
enhanced in the chemically transformed
C3H/IOT1/2 MCA16 cells after TPA addition
(Figure 2). Compared to control C18 cells the
treatment of TPA decreased the catalase activity
50% the first 120h, but for longer incubation
times (240h) the specific activity of catalase, a
peroxisome-associated enzyme, was enhanced 1.8
fold.
When mouse embryo fibroblast C18 cells were
grown in the presence of 20nM TPA for up to
240h, progressive increased activities of both
cyanide-insensitive palmitoyl-CoA dehydrogenase
and carnitine acetyltransferase (two specific enzymes
for peroxisome proliferation) were obtained (Figure
3). The increase in the peroxisomal palmitoyl-CoA
oxidation and carnitine acetyltransferase activity
was evident 24h after the addition of TPA. At
240h, TPA treatments enhanced the peroxisomal-
oxidation - 4-fold of control values. Compared to
the catalase and palmitoyl-CoA hydrolase activities
(Figure 2) no early inhibition of the activities of
peroxisomal fl-oxidation and carnitine acetyl-
transferase was observed (Figure 3). Between 24
and 240h, the level of palmitoyl-CoA oxidation in
the control cultures decreased from - 0.4nmolmin -1
mg-' protein to 0.15nmolmin-'mg-' protein.
The activities of NADPH-cytochrome c reductase,
a microsomal marker, and glutamate dehydro-
genase, a mitochondrial marker, were not effected
by TPA treatment up to 240h (Figure 3). Similar
results were obtained by TPA administration to
MCA16 cells (data not shown).
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Figure 3 Changes in the levels of peroxisomal
palmitoyl-CoA oxidation (L), carnitine
acetyltransferase (A), NADPH-cytochrome c
reductase (C1) and glutamate dehydrogenase (-) in
C18 cells treated with 20nM TPA. The control values
(nmolmin - 1 mg-1 protein) at time zero for
peroxisomal ,B-oxydation, carnitine acetyltransferase,
NADPH-cytochrome C reductase and glutamate
dehydrogenase were 0.3, 8.2, 1.8 and 20.4, respectively.
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Figure 4 Palmitoyl-CoA hydrol
catalase activity in C18 cells anm
increasing concentrations of TPI
catalase activity in C18 cells at concentrations
between 5 to 20nM. TPA (5 nM) was sufficient to
induce maximal catalase activity. Thus, MCA16
cells appear to be more sensitive than C18 cells in
inducing peroxisome-associated enzymes. A dose-
related increase in peroxisomal palmitoyl-CoA
oxidation and carnitine acetyltransferase activity
was also observed (data not shown). In the presence
\ \T of 2.5 M cycloheximide which inhibits the protein
synthesis by - 85% (Villa et al., 1980), a substantial
reduction in palmitoyl-CoA hydrolase activity and
9i catalase activity was observed in cells treated both
with TPA and tiadenol (Table I). This effect was
obtained in C18 cells as well as in MCA16 cells.
With the C18 cells, the stimulation of peroxisomal
50 100 200 fatty acid oxidation obtained by TPA and tiadenol
was reduced by cycloheximide. In the presence of
lase activity and cycloheximide, only a small reduction in carnitine
d MCA16 cells at acetyltransferase activity was observed after ~. The cells were tiadenol and TPA treatment.
exposed to the drug for 10 days and fresh medium
with drug was added 24h before harvesting the cells.
Palmitoyl-CoA hydrolase activity in the postnuclear
fraction of C18 cells (0). Catalase activity in the post-
nuclear fraction of C18 cells (U). Palmitoyl-CoA
hydrolase activity in the whole homogenate of MCA16
cells (0). Catalase activity of the whole homogenate
of MCAl6 cells (Ol).
The results of dose-response studies with TPA are
shown in Figure 4. TPA addition produced a dose-
related increase in palmitoyl-CoA hydrolase activity
over a concentration range of 5 to 20nM in C18
and 5 to 5OnM in the MCA16 cells. As shown in
Figure 4, TPA produced 2.5 fold increase in the
Discussion
TPA is a strong tumour promoter and it has been
used as a model promoter. Tumour promotion is a
process in which the altered genotype of the
initiated cell becomes expressed in such a way that
oncogenic transformation occurs. Thus, although
tumour promoters are considered to be epigenetic
in action their effects are ultimately on the genome.
Tumour promoters are not carcinogenic by
themselves, but must work in sequence with an
initiator.
Table I Effect of cycloheximide on the stimulation of peroxisomal enzyme activities by
hypolipidemic drug treatment of cultured C3H/IOTl/2 cells and chemically transformed cells,
MCA16. The cycloheximide concentration was 1 Mgml- I and the duration of treatment was 24h.
The concentrations ofTPA and triadenol were 18 nM and 10MM, respectively
Enzymic activities (nmolmin-1 mg-1 protein)
Carnitine
Palmitoyl-CoA Peroxisomal acetyl-
Cyclo hydrolase fl-oxidation transferase Catalase
heximide
Drug 1Mgml-' C18a MCAJ6b C18b C18b Ci8a MCA16b
Control - 15.1 20.1 0.25 9.6 9.2 8.5
+ 14.7 19.8 0.18 7.5 9.3 8.7
TPA - 29.1 44.5 0.73 18.7 22.2 18.7
+ 16.4 18.2 0.22 17.0 13.1 8.2
Triadenol - 22.1 48.0 0.55 12.9 20.7 14.9
+ 16.4 22.1 0.19 10.2 7.7 8.0
aThe activity was measured in the nuclear fraction. bThe activity was measured in the whole
homogenate.PEROXISOME PROLIFERATION OF TPA IN VITRO 125
A number of systems have been proposed as
models for in vitro promotion; of these mouse
embryo fibroblast C3H/IOT1/2 cells have been well
characterized (Reznikoff et al., 1973; Mondal &
Heidelberger, 1976; Lillehaug & Djurhuss, 1982).
Exposure of these cells at low density to carcino-
genic agents such as polycyclic hydrocarbons,
ultra-violet irradiation or X-rays at subcarcinogenic
doses followed by sustained exposure to phorbol
esters such as TPA results in augmented formation
of transformed foci.
A marked stimulation of cyanide-insensitive
palmitoyl-CoA oxidation, carnitine acetyltransferase
and palmitoyl-CoA hydrolase activities with a
moderate enhancement of the catalase activity, is
characteristic of the preferential stimulation of
peroxisomal enzymes associated with fatty acid
metabolism produced in vivo by tiadenol, clofibrate,
d(2-ethylhexyl)phthalate and other peroxisome
proliferators (Berge & Bakke, 1981; Berge et al.,
1984; Bakke & Berge, 1982; Moody & Reddy,
1978). Recently and partly in this study we have
shown that addition of tiadenol to cultures of C18
and MCA16 cells enhanced the corresponding
enzyme activities (Berge & Lillehaug, 1985).
Moreover, in the present study we have shown that
addition of TPA to these mouse embryo fibroblasts
enhanced the activities of peroxisomal-oxidation,
carnitine acetyltransferase, pahnitoyl-CoA hydrolase
and catalase (incubation times between 120 and
240h) while mitochondrial and microsomal marker
enzymes showed little changes in activity. The first
120h of cultivation with TPA decreased the
catalase activity (Figure 2). This observation is in
agreement with results from Solanski et al. (1981)
reporting that TPA treatment for 16h decreased the
catalase activity in mouse epidermal cells. A similar
time course was observed for the palmitoyl-CoA
hydrolase activity. The initial inhibition of
palmitoyl-CoA hydrolase and catalase activity may
be related to the promoting activity of TPA while
the stimulation observed during prolonged
treatment may be explained, by the growth
stimulating and the second stage tumour promoting
properties of TPA. The inhibitory effect of
cycloheximide on peroxisomal fl-oxidation indicates
that the increases produced in cell culture were
largely the result of de novo protein synthesis. The
low inhibitor effect of cycloheximide on the activity
of carnitine acetyltransferase after TPA treatment
may be explained by a stimulating effect on the
enzyme itself rather than enhanced protein
synthesis. Apart from being a peroxisome-associated
enzyme, carnitine acetyltransferase is also localized
to the mitochondria. The activity of glutamate
dehydrogenase was not changed after TPA
administration. Thus, these observations further
complicate the interpretation of the effect of
cycloheximide on carnitine acetyltransferase activity.
The two-stage carcinogenesis process has been
studied in several in vitro cell culture assays. The
culture system used in the present study is
fibroblastic whereas well characterized two-stage
systems are also epithelial. The end point analyzed
in the present study seemed to be a late irreversible
event in carcinogenesis since the foci are irreversibly
growing and tumourigenic (Mondal & Heidelberger,
1976) in contrast to the papillomas produced in the
well-characterized epidermal system in vivo which
are reversibly growing (Burns et al., 1978) and the
cells from which are non-tumourigenic (Pera &
Gorman, 1984). Moreover, TPA has not been
demonstrated to influence any of the irreversible
steps in epidermis in vivo (Verma & Boutwell, 1980).
The first stage of promotion is reversible and
melanomas are still promoted by TPA in species
where papillomas are not (Sisskin & Barrett, 1981).
Thus, these observations raise the question whether
in general promoting agents produce similar effects
in in vivo carcinogenesis and in vitro cell
transformation.
Although we have not used electron microscopy
for assessing these peroxisomal changes, the data
suggest that the classical tumour promoter TPA has
peroxisomal effects and may be classified as a
peroxisome proliferator. Peroxisomes oxidize
activated long-chain and medium-chain fatty acids
and the removal of two carbons results in
generation of one molecule of H202. Thus, H202 is
generated as a by-product of the peroxisomal /B-
oxidation. The time course study demonstrated that
the peroxisomal fl-oxidation was enhanced greater
and earlier than the catalase activity after TPA
treatment e.g. after 180h of cultivation the
peroxisomal fl-oxidation was increased - 3-fold
while the catalase activity was unaltered. Catalase is
not so very effective in destroying H202 at low
concentrations (Chance et al., 1979). Thus, the
H202 generated by peroxisomes can escape
degradation by catalase. None of the tested
carcinogenic peroxisome proliferators has been
shown to be mutagenic in bacterial assays (Warren
et al., 1980). However, H202 and related oxygen
free radicals are known to be mutagenic in repair-
deficient strains of Escherichia coli (Demple et al.,
1983). Furthermore, H202 has also been shown to
be carcinogenic in rats and mice. Furthermore, Fahl
et al. (1984) have shown that DNA damage is
related to increased H202 generation by
hypolipidemic drug-induced liver peroxisomes.
Recently, we have shown that hypolipidemic drugs
such as clofibrate and niadenate, classified as strong
peroxisome proliferators, show tumour promoting
but no carcinogenic activity in vitro (Berge &126 J.R. LILLE.HAIJG & R.K. BERGE
Lillehaug, 1985). As clofibrate induces hepato-
cellular tumours in both mice and rats when
chronically administered in the diet (Reddy et al.,
1980), these observations raise the question whether
mutagenic metabolites are generated by
hypolipidemic drug-induced liver peroxisomes.
Induction of hepatocellular tumours may be related
to biologically active products of the proliferated
peroxisome population rather than a direct drug
effect. Therefore, the promoting activity of TPA,
classified as a peroxisome proliferator, may be
related to biologically active products of the
proliferated peroxisome population e.g. H202.
In order to further assess the relevance of the
data to tumour promotion and transformation, it
will now be of interest to determine whether the
number of foci in this culture system show a similar
dose-dependence on TPA to the increased activity
of peroxisomal #-oxidation.
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